The use of perioperative cardiopulmonary exercise testing (CPET) to evaluate the risk of adverse perioperative events and inform the perioperative management of patients undergoing surgery has increased over the last decade. CPET provides an objective assessment of exercise capacity preoperatively and identifies the causes of exercise limitation. This information may be used to assist clinicians and patients in decisions about the most appropriate surgical and non-surgical management during the perioperative period. Information gained from CPET can be used to estimate the likelihood of perioperative morbidity and mortality, to inform the processes of multidisciplinary collaborative decision making and
Use of preoperative cardiopulmonary exercise testing (CPET) to evaluate the risk of adverse perioperative events and inform the perioperative management of patients undergoing surgery has increased over the past decade, particularly in the UK. 1, 2 With the rapid uptake of CPET, standardization is key to ensure valid, reproducible results that can inform clinical decision making.
Recently, an international Perioperative Exercise Testing and Training Society (POETTS) has been established (www.poetts. co.uk). This body developed from the UK National Perioperative CPET forum and has the specific aims of: (1) promoting the highest standards of care for patients undergoing exercise testing, exercise training, or both in the perioperative setting and to promote the professional practice of exercise testing, exercise training, or both in the perioperative setting; (2) promoting and delivering training and education in exercise testing, exercise training, or both in the perioperative setting including advising on education and training curricula for medical and healthcare practitioners; (3) promoting the development, conduct, and dissemination of audit, quality improvement, research and innovation to further the development of perioperative exercise testing, training, or both. These clinical cardiopulmonary exercise testing guidelines have been developed by consensus by the POETTS after systematic literature review. The guidelines have been endorsed by the Association of Respiratory Technology and Physiology (ARTP). The guidelines represent what is considered to be best practice by expert consensus and by setting a standard the intention is to help all who do perioperative CPET to reach this standard. They will be used to benchmark practice and subsequently will be revised in the light of new information or evidence.
Methods

Guideline development
An early set of UK CPET guidelines (unpublished) was pro- 
Systematic review
The writing process was informed by multiple published systematic reviews of the relevant literature including Smith and colleagues, 6 Hennis and colleagues, 7 and Moran and colleagues. 8 In addition, to identify recently published studies, we performed repeated updated PubMed systematic searches during the development of this manuscript (until submission) based on the search strategy Hennis and Grocott 7 and using the follow search terms: 'CPET/surgery', 'CPEX/surgery', 'CPX/ surgery,' 'cardiopulmonary/exercise testing/surgery', 'VO 2 peak/surgery', 'VO 2 max/surgery' 'AT/surgery and 'Anaerobic threshold/surgery.'
Strength of recommendations and levels of evidence
To indicate the basis on which recommendations were made, all evidence was classified according to an accepted hierarchy of evidence that was originally adapted from the US Agency for Healthcare Policy and Research Classification. 9 Each recommendation is graded AeD based on the level of associated evidence using a scheme formulated by the Clinical Outcomes Group of the NHS Executive that has been used in NICE guidelines 10 (see Supplementary Appendix S1).
In contrast to questions of clinical efficacy and effectiveness, the practice recommendations within these guidelines relate to the indications, organization, conduct, and physiological interpretation of perioperative CPET. Such questions are rarely, if ever, amenable to direct evaluation through randomized controlled trials (RCTs); therefore, all recommendations are graded B (well-conducted clinical studies but no RCTs on the topic of recommendation; or extrapolated from RCT or systematic review), C (expert committee reports or opinions/clinical experiences of respected authorities OR extrapolated from well-conducted clinical studiesdthis grading indicates that directly applicable clinical studies of good quality are absent or not readily available), or D (recommended good practice standard based on the clinical experience of the guidelines development group).
Guidelines scope
CPET evaluates the integrated physiological response to exercise and provides an objective measure of exercise capacity (functional capacity or physical fitness). It also permits interrogation of the aetiology of exercise intolerance when exercise capacity is abnormal. Exercise capacity is predictive of postoperative outcome, 11 reflecting the physiological reserve available to respond to the stress of surgery and postoperative recovery. This guideline is intended to provide guidance on the use of CPET perioperatively. The use of CPET for other applications has been comprehensively covered elsewhere.
3e5,12e15
Indications and contraindications for CPET and also for guiding exercise-training interventions prior to surgery, immediately after surgery, or both. 33, 34 The evidence supporting CPET is continuously evolving and consequently the indications for CPET require regular reassessment.
Recommendations: Indications for CPET (1) To estimate the likelihood of perioperative morbidity and mortality and contribute to preoperative risk assessment (Grade B). (2) To inform the processes of multidisciplinary shared decision-making and consent (Grade C). 
Contraindications for CPET
Published contraindications to CPET have addressed its use as a diagnostic and prognostic tool for patients with cardiac or respiratory disease, to monitor disease progression in chronic cardiorespiratory disease, to quantify exercise capacity, and to evaluate likely causes of exercise intolerance. 3, 15 These are largely based on the expert opinion of respected authorities. Contraindications and relative contraindications to exercise testing in the perioperative setting are summarized in Table 1 . These are based on recommendations in other areas of CPET modified for the perioperative context to take into account the specific patient population (Grade C). Patients with relative contraindications should be directly supervised by a physician (Grade C). For relative contraindications to exercise testing, the risks and potential benefits of undertaking CPET should be considered on a patient-by-patient basis both before and during the test (Grade D). If the risk-benefit relationship changes as the test progresses, the test can be terminated earlyda submaximal test (Grade D). For example, in a colorectal cancer patient with newly identified asymptomatic severe aortic stenosis, CPET may be considered to delineate the functional impairment caused by the valve stenosis. The test may help determine the relative priority of valve replacement and tumour resection. However, if the patient developed chest pain or hypotension during the test, this would indicate critical stenosis and an increased risk of syncope, and should lead to test termination.
Perioperative CPET service structure and supervision
A perioperative CPET service should be managed and led by an individual expert in perioperative CPET (Grade C). Perioperative CPET expertise incorporates an understanding of the The competencies required for each of these stages are different. Within a CPET service different individuals may perform each of the three stages of the testing and interpretation process. Alternatively, a single individual may be able to perform all three stages. Stages 1 and 2 may be performed by non-clinicians, but clinical expertise in perioperative medicine is required for stage three. Competence and expertise in each stage of the CPET process should be defined by specific training and documented experience, rather than defined medical roles (e.g. doctor, nurse, clinical physiologist; Grade C). 5 All competent CPET practitioners and advanced practitioners must be able to identify and manage adverse events in relation to CPET by discriminating between normal and abnormal responses to exercise including abnormal symptoms, hypertension, hypotension, abnormal arterial O 2 saturation [measured by pulse oximetry (SpO 2 )] and ECG evidence of arrhythmia and ischaemia (Grade C). 5 CPET practitioners and advanced practitioners must have appropriate knowledge and experience in first aid and resuscitation (Grade C).
5
A minimum of two members of staff should be directly available for every test, one of whom should be a competent CPET advanced practitioner (Grade D 
Baseline data collection
Baseline data collection should include patient demographic information, the reason for referral and the proposed surgery. 5 The patient's medical history should be reviewed with particular attention to cardiac and respiratory disease to identify potential contraindications to exercise testing. 5 A full drug history should also be taken to identify medication that may interfere with the exercise response. 5 A recent haemoglobin level should be reviewed, since anaemia may impair exercise capacity (Grade D).
36,37
Conduct of the exercise test (Grade C, good practice recommendations, unless otherwise stated)
The exercise protocol, equipment, and quality control of perioperative CPET are discussed below. The recommendations within this section are based on key position statements and policy documents from national and international specialist bodies that use CPET in other clinical contexts and represent good practice standards.
3e5,12,13
Exercise protocol (Grade C)
Cardiopulmonary exercise testing provides a global assessment of the integrated response of the pulmonary, cardiovascular, metabolic, and haematological systems. Key is the integration of respired gas analysis (O 2 and CO 2 concentrations) with ventilatory flow measurements, thereby enabling calculation of O 2 uptake ( _ VO 2 ) and CO 2 output ( _ VCO 2 ), typically on a breath-by-breath basis, under conditions of progressively increasing physiological stress imposed by a defined profile of external work rate (WR).
Heart rate (HR), SpO 2 , arterial blood pressure, and 12-lead ECG (for rate, rhythm, and S-T segment morphology evaluation) should be monitored throughout the test.
3e5,12,13 Resuscitation equipment including supplemental O 2 must be immediately accessible.
3e5,12,13
For perioperative CPET, the rapid ramp (or incremental) exercise test performed to the limit of tolerance should be used. 38 The advantages of this protocol are as follows: (1) it evaluates the exercise response across the entire range of functional capacity; (2) the initial WR is low and there is a relatively short duration of high intensity exercise; (3) the entire protocol is of short duration, with 8e12 min of exercise during the incremental phase; (4) it permits assessment of the normality or otherwise of the exercise response; (5) it permits identification of the cause of functional exercise limitation; and (6) it gives an appropriate frame of reference for training or rehabilitation targets. Submaximal tests, (stopping the incremental ramp above the anaerobic threshold but before peak exercise) were initially widely used in the perioperative setting, primarily because of safety concerns and may still be considered in some clinical contexts, for example, in patients with angina or moderate to severe aortic stenosis. However, maximal tests to the limit of tolerance provide additional information that may have prognostic and diagnostic utility and are preferred.
Cycle ergometry has been used in all bar one of the published perioperative CPET cohorts. Cycle ergometry permits accurate determination of the external WR and thus, for example, evaluation of the _ VO 2 eWR relationship, which is difficult with a treadmill. 39 Consequently, cycle ergometry (using an electromagnetically braked ergometer) is the preferred mode of exercise for PCPET. For patients who are unable to perform cycle ergometry, arm cranking may be considered, although the risk thresholds for this modality of exercise in the perioperative setting have not been identified. 40 A period of approximately 3 min of resting data collection (rest phase) should be followed by 3 min of resistance-free pedalling (unloaded cycling phase) and then a continuous gradual, uniform increase in WR until the limit of tolerance is attained (incremental phase). The ramp slope (W min
À1
) is selected to produce 8e12 min of exercise during the ramp phase. 3 
where:
and for males:
or for females:
The validity of such predictive algorithms in a general surgical population has not been established. 42 Anecdotal evidence suggests that exercise capacity of the surgical patient population tends to be overestimated by these equations; a reduction in the calculated value should therefore be considered (Grade D).
CPET equipment (Grade C) Calibration and quality control (Grade C)
The accuracy and reproducibility of the values obtained during testing is dependent on meticulous quality control. 3, 4, 15, 39 Calibration of primary sensors for flow and O 2 and CO 2 gas measurement should be performed immediately before each exercise test. The calibration should consider barometric pressure, ambient humidity, and temperature. While the precise calibration procedures will vary with the model and manufacturer of the metabolic cart, there are certain underlying principles that should be followed. The flow sensor should be calibrated for volume with a precision syringe (typically 3 l) over a physiological range of flow rates. Calibration gas mixtures for the O 2 and CO 2 sensors should be prepared by gravimetric weighing to ensure a concentration accuracy of ±1%. Sensor calibration should be performed at two points, within the range for inhaled (21% O 2 and 0% CO 2 in N 2 ) and exhaled gas compositions (e.g. 15% O 2 and 5% CO 2 in N 2 ). Because of the transport delay associated with the gas concentration sensors (a phase delay typically in the region of 250 ms), the flow and gas concentration signals have to be time-aligned prior to further processing. This phase delay should be measured prior to each test rather than assumed, as small deviations from the correct value can have significant impact on gas exchange computations. 4, 15, 29, 39, 45 It is measured as the delay between the imposition of a step change in gas concentration at the distal end of the sample line and the resulting gas concentration response at the respective sensor (phase delay), and values should lie within the manufacturer's stated range. The performance of the gas exchange algorithms cannot be assessed in the routine pretest calibration phase. This requires simultaneous comparison of the metabolic cart responses with those obtained with an accepted independent standard. The contemporary (and expensive) 'gold standard' method uses an automated gas exchange simulator. This comprises a reciprocating piston system that generates 'expired' gas to simulate metabolic rates by injecting a precision gas mixture into a chamber at precisely metered rates to mix with inspired air, thus allowing comparison of 'measured' breath-by-breath values of _ VO 2 , _ VCO 2 , and ventilation ( _ VE) with predicted values. 46 It has been proposed that the measured outputs and their variation with changes in pump frequency should lie within~3%. Values falling outside this range should prompt a comprehensive reassessment of the entire monitoring system. 3 Small, progressive deteriorations in sensor performance and sample line transit delay over time may have a significant effect on gas exchange computation. Validation against a gas exchange simulator may be performed annually as part of the metabolic cart service. A practical (and inexpensive) alternative is provided by regular 'biological quality control' (conducted monthly or more frequently), utilizing responses of a 'standard' subject (typically a member of the laboratory staff familiar with testing procedures). 13, 39, 47, 48 It is recommended that the subject performs two sub-anaerobic threshold (AT) constant WR tests, each of at least 6 min duration, with the steady-state _ VO 2 , _ VCO 2 , and _ VE responses at each WR being obtained by averaging data over the final 2 min of the test (i.e. when a steady state has been achieved; Fig. 1 ). This allows the development of a serial quality control database comprising absolute _ VO 2 , _ VCO 2 , and _ VE responses at standardized WRs, as well as derived indices such as the respiratory exchange ratio (RER, _ VCO 2 = _ VO 2 ) and the slope of the _ VO 2 À WR relationship (D _ VO 2 =DWR), which is relatively independent of age, gender, and fitness. Differences in 'expected' response can then be identified, both in terms of previous subject performance and also relative to normal population values. While there are no formal recommendations for assigning a 'significant' change relative to a quality control database, decisions could be based on: (1) responses falling outside the database 95% confidence interval 3 ; (2) _ VO 2 at a given WR deviating by >5e10% of database values 15 or >10% of the predicted value, 49 where Ideally, the cycle ergometer should be calibrated at least annually and whenever it is moved (which can disturb the calibration), using a device such as a dynamic torque meter. The calibration should be linear from 0 to~400 watts, and independent of pedalling cadence over a physiologically reasonable range.
54e56 Sudden deviations in the normal slope value of the _ VO 2 eWR relationship warrant investigation, both of cycle ergometer and metabolic cart performance.
Practicalities of test conduct (Grade C)
Resting spirometry should be performed to measure forced vital capacity and forced expiratory volume in 1 s (FEV 1 ).
Maximum voluntary ventilation can be estimated from FEV1 as (FEV 1 Â 35) or (FEV 1 Â 40). 57, 58 The patient should be familiarized with the cycle ergometer and the breathing assembly (facemask or breathing valve and mouthpiece), and should be instructed to give their 'best effort' but counselled to stop if symptoms such as chest pain develop. The patient should be discouraged from talking during the test, as this will compromise data quality; an alternative method of communication should be established before commencing the test (thumb up ¼ yes, thumb down ¼ no). The patient should understand that they can stop at any time, whilst recognizing that the aim is to pedal for as long as possible. During testing, data should be displayed in both tabular and graphical formats to monitor for abnormalities; core variables are presented in Table 2 .
The exercise test consists of four main phases: rest, unloaded cycling, ramp exercise, and recovery.
Rest (3 min)
A minimum of 3 min of resting data should be recorded, with the ECG being monitored for ischaemia or arrhythmia. If hyperventilation is present (RER >1.0) this should be allowed to settle before commencing the next phase of the test. It is important to note that sustained hyperventilation can precipitate a premature 'false positive' or 'pseudothreshold' for AT estimation, which can obscure events triggered by the actual threshold (see False positives below). 59 Also, if the RER is persistently <0.7, the test should be halted as this is suggestive of inaccurate calibration and the calibration procedure should be repeated.
Unloaded cycling (3 min)
Unloaded cycling allows functionally limited patients to acclimate to pedalling. Three minutes is sufficient in healthy individuals for HR, _ VO 2 , _ VCO 2 , and _ VE to attain new steady states prior to the ramp phase commencing. The patient is encouraged to adopt a comfortable pedalling cadence, between 55 and 75 rpm throughout the test. 3, 4, 15, 39 Ramp phase (8e12 min)
It is recommended that this phase is started without providing any cues to the patient, who should be instructed to continue pedalling for as long as possible. The limit of tolerance is defined as the point at which the patient is unable to maintain the pedalling cadence despite encouragement. The Borg score may be recorded at the end of the exercise to evaluate subjective effort.
Recovery (~5 min)
Once the load is removed, the patient should be encouraged to pedal for a further period to prevent venous pooling in the legs and consequent syncope. Monitoring should continue until any dysrhythmia or ST changes have reverted to baseline, HR has fallen to within 10 beats min À1 of resting values and blood pressure has returned to baseline.
Indications for stopping the test (Grade C)
An exercise test may be terminated as a result of ostensive 'good effort' (i.e. with symptom limitation) or because of the development of clinically-inappropriate symptoms. The reasons for stopping the test should be recorded, both from the subject's and the operator's perspectives. For example, 'The patient stopped pedalling due to fatigue', 'The patient failed to maintain a cadence greater than 40 rpm for more than one minute despite encouragement', or 'The patient felt light headed'. Commonly accepted criteria for the operator terminating an exercise test prematurely are listed in Table 3 . These are not absolute criteria and should be interpreted within the context of individualized risk of continuing the test and benefit from gaining more information.
Interpretation of the exercise test
Interpretation of a PCPET includes two main elements: (1) integration and interpretation of the physiological data to provide a comprehensive description of the patient's exercise capacity and the main causes of exercise limitation. (Table 4) ; and (2) interpretation of the implications of the patient's exercise limitation for their perioperative risk and recommendations regarding preoperative interventions (beyond the scope of this guideline; to be addressed in a subsequent guideline). While the former can be standardized, the latter is based on incorporation of functional capacity into the overall patient preoperative assessment. The latter is an evolving field with a requirement for frequent (re-)evaluation of the clinical literature and will be the subject of a later guideline. In this guideline we focus on the interpretation of exercise capacity, which is a fundamental consideration in perioperative risk evaluation. We will also discuss the ventilatory equivalents for CO 2 as this is associated with surgical outcome in several surgical cohorts. 17, 26 It is likely that as the field develops other variables may be related to outcome and these guidelines will be reviewed and revised as appropriate. Detailed interpretation of underlying cardiac and respiratory pathology is covered elsewhere. 3e5,12e15 An integrated approach to perioperative CPET interpretation and the key elements of a perioperative CPET report are also considered.
Data averaging and data presentation (Grade C, good practice recommendations, unless otherwise stated)
The breath-by-breath data should be averaged prior to graphical display and interpretation using, for example, a moving average (e.g. middle five of seven breaths), a breathbased average (e.g. three to five breaths), or a time-based average (e.g.~20 s), to reduce the influence of biological 'noise'. 60, 61 The procedures for data editing and data averaging should be applied consistently within a CPET laboratory; otherwise, results may be adversely influenced. 62, 63 The quality of the test should also be commented upon in the report. Reporting exercise capacity or functional capacity (Grade C, good practice recommendations, unless otherwise stated)
The terms functional capacity, exercise capacity, and exercise tolerance are used synonymously to describe the patient's ability to perform exercise and thus provide insight into his/ her physiological reserve. Two variables are widely used to describe exercise capacity in perioperative CPET: _ VO 2peak and the AT. These variables are both associated with postoperative morbidity and mortality. 8 _ VO 2peak ((see Table 5 for summary) _ VO 2peak is a metabolic rate defined as the highest oxygen uptake ( _ VO 2 ) attained on a rapid incremental test at end-exercise. As such, it is reflective of the patient's 'best effort' but it may not reflect what was potentially achievable for that patient (i.e. it is not necessarily a physiologically maximal end-point).
The highest _ VO 2 that could be attained by a patient is defined as the maximum _ VO 2 _ VO 2max 'the oxygen uptake during an exercise intensity at which actual oxygen uptake reaches a maximum beyond which no increase in effort can raise it' (a physiological end point). 64 Rigorous determination of _ VO 2max relies on demonstration of a plateau in _ VO 2 in the face of increasing WR, e.g. _ VO 2 increasing by <2 ml kg À1 min À1 65 ( or 50% of the predicted increase over 1 minute). The classical approach for determining _ VO 2max is demanding as it requires the completion of several discrete exhausting constant WR tests. 66, 67 _ VO 2max reflects the attainment of a physiological limitation at one or more points in the O 2 transport pathway between the lungs and the site of the mitochondrial O 2 consumption at the cytochrome oxidase terminus of the electron transport chain. 68 Thus, dysfunction in the responses of the convective pulmonary or vascular O 2 fluxes, or in the diffusive pulmonary or muscletissue O 2 fluxes will result in an abnormally low _ VO 2max . _ VO 2peak may reflect the patient's physiological limits but this can only be assumed if there is a plateauing of the _ VO 2 eWR relationship as the limit of tolerance is approached. 69 Unfortunately not all individuals will exhibit a plateau during rapid incremental exercise even when they have attained a physiological maximum. 70, 71 In the absence of a plateau in the _ VO 2 response, additional criteria may be used to help support _ VO 2peak representing a physiologically maximal effort, including a peak HR within 10 beats min À1 of the age-predicted maximum and a peak RER of >1.10. 72 It should be noted, however, that pathology or medication may affect either or both of these criteria in a patient population, for example, chronotropic incompetence or b-blockade reducing the maximum HR response or respiratory-mechanical flow limitation limiting exercise before the generation of a metabolic acidosis in severe chronic obstructive pulmonary disease resulting in a peak RER < 1. Thus, an effort may be physiologically maximal without these criteria being attained and consequently they should be interpreted with caution in the light of the entire exercise response. Furthermore, _ VO 2peak may be affected by the patient's volitional exercise effort. 73 Despite the uncertainty regarding the presence of physiological limitation at _ VO 2peak , importantly _ VO 2peak has been shown to predict both postoperative morbidity and mortality in surgical populations and so has predictive clinical utility.
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In addition, it is both easy to identify and reproducible. A good patient effort is aided by familiarization prior to the test as well as encouragement by the investigator during the later stages of the test.
_ VO 2peak should be calculated as an averaged value over a short period extending from the end-exercise point back into the incremental phase to minimize the influence of breath-tobreath noise, i.e. capturing the true end-point without weighting it unduly towards submaximal breath values. 63, 74 A reasonable choice is a period of~20 s or~three to five breaths, with the value being reported, as an absolute value (ml min À1 or litres min À1 ) or indexed to bodyweight (ml kg À1 min À1 ). With good subject effort, _ VO 2peak is independent of the WR incrementation rate. 75 However, this is not the case for peak WR, which is progressively greater the faster the rate of WR increase (i.e. the greater the incremental ramp gradient) because of the underlying _ VO 2 response kinetics. 75 As a consequence, peak WR varies with the ramp gradient and consequently is not as reproducible as _ VO 2peak . In summary, _ VO 2peak is a measure of maximal exercise capacity but may be affected by volition. Practically, _ VO 2peak is easy to identify and reproducible. Importantly, it predicts postoperative outcome in major surgical patients.
Anaerobic Threshold (AT) ( Table 6 for summary)
The AT provides an index of submaximal, sustainable exercise capacity, and if present cannot be volitionally influenced by the patient. Importantly, it predicts postoperative complications and mortality in a wide range of surgical populations with more precision than other CPET variables.
The AT is a metabolic rate defined as the _ VO 2 above which arterial [lactate] first begins to increase systematically during incremental exercise. 76 The lactate accumulates as a consequence of anaerobic glycolysis and its associated metabolic acidosis. However, the causes of this remain controversial. 15,77e82 The AT may also be termed the lactate threshold, lactic acidosis threshold, ventilatory threshold, or gas exchange threshold. 15 In the perioperative CPET literature, the term anaerobic threshold has been used consistently and is consequently preferred (Grade D). The AT is conventionally estimated non-invasively from respired gas measurements using an incremental ramp exercise test. 3, 15, 83 The AT should be identified using a three point discrimination technique as described by Whipp and colleagues. 83 The modified V-slope method can be used to identify the inflection point in the CO 2 output ( _ VCO 2 ) response and this should be supported by evaluating changes in the ventilatory equivalents and end-tidal partial pressures of O 2 and CO 2 to confirm hyperventilation with respect to oxygen but not to carbon dioxide. 83e85 The methods used to identify the AT are summarized in Table 6 .
AT Criterion 1: Excess VCO 2 above the AT is identified using the V-Slope method:
The increasing anaerobic glycolysis above the AT results in a progressive metabolic acidosis. This is buffered to an extent by intra-and extracellular bicarbonate [HCO 3 e ] in the exercising muscle. Consequently, arterial [HCO 3 e ] starts to decrease as WR increases above the AT, essentially mirroring the developing [lactate] increase. These buffering reactions generate CO 2 that is additional to the CO 2 produced during aerobic metabolism (i.e. 'excess' _ VCO 2 ). Thus _ VCO 2 is supplemented and the _ VCO 2 e _ VO 2 relationship steepens at the AT causing an inflection in the _ VCO 2 e _ VO 2 response. The AT is identified by this inflection point in the _ VCO 2 e _ VO 2 response and can be detected by the V-slope method (Fig. 2) or by the modified V-slope method (Fig. 3) . 84, 85 V-slope method (Fig. 2) . At the start of the incremental phase of the test, the _ VCO 2 response initially lags behind that of _ VO 2 reflecting its slower response kinetics. The _ VCO 2 then increases linearly with respect to _ VO 2 . The slope of the _ VCO 2 e _ VO 2 relationship (D _ VCO 2 =D _ VO 2 ) in this linear region has been termed S 1 and has a value typically slightly less than one in patients on a typical western diet (i.e. reflecting the influence of the respiratory quotient). Immediately above the AT, the gradient of the _ VCO 2 À _ VO 2 relationship becomes steeper as excess _ VCO 2 develops, with a slope termed S 2 . The AT is the point at which the linear regression lines of the S1 and S2 components intersect (the S 1 eS 2 inflection point). The initial portion of the _ VCO 2 À _ VO 2 relationship that is distorted by changes in body CO 2 storesdthe 'kinetic' phase (approximately the first 60 s exercise) and the portion of the curve above the respiratory compensation point (RCP; defined as >15% change in gradient in _ VEe _ VCO 2 relationship are excluded from the analysis. 84 In those cases in which there is not a sufficiently linear S 2 region, the first detectable point of _ VCO 2 acceleration relative to _ VO 2 can be used as an alternative AT estimator. Modified V-slope method (Fig. 3) . The modified V-slope method is an alternative to the V-slope method, which has particular utility when the _ VCO 2 e _ VO 2 relationship cannot be partitioned into two linear segments (i.e. a curvilinear response), which is common. This is based on the assumption that the S 1 slope should have a value of 1.0 or less (the highest respiratory quotient, for carbohydrate, being 1.0) and that the S 2 slope should have a value >1.0 (because of excess _ VCO 2 ). Ensuring that the _ VO 2 and _ VCO 2 axes are scaled identically, the effective S 1 eS 2 inflection point can be estimated by 'running in' a unitary tangent or 'line of one' (i.e. line with gradient D _ VCO 2 =D _ VO 2 ¼ 1.0) from the right until it first impacts on the _ VCO 2 À _ VO 2 relationship. The _ VO 2 at which this occurs is taken as the AT, as all higher data points manifest excess _ VCO 2 (i.e.
with D _ VCO 2 =D _ VO 2 > 1.0.). The V-slope and modified V-slope methods depend solely on the physicochemical reaction of metabolically-produced hydrogen ions with bicarbonate and as such the occurrence of the breakpoint is independent of chemoreceptor sensitivity and the ventilatory response to exercise. The V-slope methods are therefore particularly useful for AT estimation in conditions characterized by poor respiratory chemosensitivity or premature respiratoryemechanical limitation that prevent Table 6 Anaerobic threshold (AT) definition, measurement and key characteristics
ATddefinition, identification, and key characteristics
The AT is a metabolic rate expressed in ml kg ¡1 min ¡1 or ml min
¡1
. It is defined as the _ VO 2 above which arterial (lactate) first begins to increase systematically during incremental exercise reflecting increased glycolysis.
The AT should be identified using a three-criterion discrimination technique (Fig. 4) AT Criterion 1: identify excess _ VCO 2 relative to _ VO 2 above the AT by:
Modified V-slope: (Fig 3) The tangential breakpoint in the _ VCO 2 À _ VO 2 relationship from a line with a gradient of one ('line of one;
The breakpoint is identified by moving the line of one from the right until it first impacts on the _ VCO 2 e _ VO 2 relationship. The _ VO 2 at which this occurs is taken as the AT. OR V-slope: (Fig. 2) The inflection point in the _ VCO 2 e _ VO 2 relationship identified as the intersection point of the linear regression lines of the S1 (below AT) and S2 (above AT) components. The initial kinetic portion of the relationship and the portion above the respiratory compensation point are excluded from the linear regression.
AT Criterion 2: identify hyperventilation relative to oxygen (Fig. 4) The _ VE/ _ VO 2 _e _ VO 2 relationship having been flat or decreasing begins to increase and does not return to baseline. The P ET O 2 À _ VO 2 relationship having been declining or flat begins to increase and does not return to the baseline.
AT Criterion 3: exclude hyperventilation relative to CO 2 ( Fig. 4) at the AT inflection point identified by criteria 1 and 2:
The _ VE/ _ VCO 2 relationship remains constant or continues to decrease at the point where _ VE= _ VO 2 starts to rise systematically. There is no reciprocal decrease in P ETCO 2 at the point where P ETO 2 starts to rise systematically. the development of a discernible _ VE response to excess _ VCO 2 (e.g. chronic obstructive pulmonary disease). 84 AT Criterion 2: Hyperventilation relative to O 2 : the ventilatory equivalent for O 2 and end tidal PO 2 at the AT (Fig. 4) At the AT, the excess _ VCO 2 generated from anaerobic glycolysis results in a proportional increase in _ VE. There is no equivalent increase in _ VO 2 at this point. Consequently _ VE is driven by _ VCO 2 and starts to increase at a greater rate with respect to _ VO 2 ; i.e. hyperventilation relative to O 2 . This is reflected in _ VE= _ VO 2 and alveolar end-tidal PO 2 (P ET O 2 ) both starting to increase at the AT. Thus at the AT the following occur: (1) the _ VE= _ VO 2 À _ VO 2 relationship having been flat or decreasing to a nadir begins to increase systematically and (2) the P ET O2 e _ VO 2 relationship having been declining or flat begins to increase systematically.
AT Criterion 3: no hyperventilation relative to CO2: the ventilatory equivalent for CO2 and end tidal co2 at the AT The _ VCO 2 e _ VO 2 (V-slope) relationship and hyperventilation relative to oxygen do not alone provide a sufficiently rigorous criterion for AT estimation. It is important that non-specific hyperventilation (with an attendant fall in arterial P CO2 (Pa CO2 )) due to factors such as anxiety, pain, or arterial hypoxaemia is first excluded as a cause of the excess _ VCO 2 identified by the V-slope method. This requires examination of the ventilatory consequences of the excess _ VCO 2 . Below the AT, _ VE is proportional to _ VCO 2 such that alveolar end-tidal P CO2 (P ET CO 2 ) and arterial P CO2 remain stable. This proportionality is initially maintained above the AT because the normal compensatory hyperventilation expected with an exerciseinduced metabolic acidosis (which lowers the Pa CO2 and thereby compensates for the falling pH) does not occur immediately at the AT for rapid incremental exercise. 86e88 Rather, respiratory compensation is delayed to a somewhat higher WRddefined as the RCP. The exact location of the RCP depends on factors such as the WR incrementation rate and peripheral (carotid body) chemoreflex responsiveness. 89, 90 This delay, which is possibly consequent to slow carotid chemosensory response kinetics generates a phase of 'isocapnic buffering' between the AT and RCP within which neither P ET CO 2 nor Pa CO2 decline (i.e. there is no immediate hyperventilation relative to CO 2 at the AT). 90 To ensure that the inflection point identified as the AT is not as a result of nonspecific hyperventilation that could be from pain, hypoxaemia or primary hyperventilation syndrome, hyperventilation relative to CO 2 at the AT must be excluded by confirming the following: (1) _ VE= _ VCO 2 remains constant or continues to decrease at the AT as the _ VE= _ VO 2 starts to rise systematically and (2) the absence of a fall in P ET CO 2 at the AT. This is because ventilatory compensation for the metabolic acidosis above the AT which causes a reduction in Pa CO2 does not occur until several minutes later during rapid incremental exercise tests (i.e.at RCP).
Above the RCP towards the end of the exercise test, the _ VCO 2 À _ VO 2 and _ VE À _ VCO 2 relationships steepen, as respiratory compensation develops in response to the metabolic acidosis of exercise; i.e. reflecting the loss of CO 2 from arterial stores as Pa CO2 is driven down by hyperventilation.
Anaerobic Threshold Identification (Table 6 for summary)
In summary, rigorous AT estimation requires that support be sought not only from excess _ VCO 2 but also from the profiles of the ventilatory equivalents and end-tidal partial pressures for O 2 and CO 2 to establish the development of hyperventilation relative to O 2 but not with respect to CO 2 . This requires the demonstration that, coincident with the modified V-slope break point, _ VE= _ VO 2 and P ET O 2 start to increase (i.e. hyperventilation relative to O 2 ), but with no coincident increase in _ VE= _ VCO 2 or decrease in P ET CO 2 (i.e. no hyperventilation relative to CO 2 ). In practice, it can be the case that noisiness in the data set may preclude reliable discrimination of all three break points simultaneously, in which case greater weight should be placed on the V-slope indices.
Automated Anaerobic Threshold
The V-slope method is used in the majority of commercial metabolic carts to identify an automated AT. These automated ATs should only ever be used as a guide and should be interpreted with caution. In the presence of a curvilinear _ VCO 2 e _ VO 2 relationship linear regression may not accurately identify the AT. In addition, care should be taken to ensure that the kinetic phase at the start of the incremental ramp and the portion of the data above the respiratory compensation point are excluded from the regression analysis, which requires manual interrogation of the data. Finally, automated V-slope methods do not use confirmation of the AT by the ventilatory criteria discussed above and thus, particularly in the presence of noisy data, may not accurately identify the AT.
Anaerobic Threshold -False positives or pseudothresholds
Transient volitional hyperventilation occurring just prior to the start of a ramp exercise test or in its early stages can compromise AT estimation and cause a pseudothreshold, where the criteria for an AT can be identified but before the onset of the exercise-induced metabolic acidosis. 59 In such circumstances, acute hyperventilation causes acute wash-out of CO 2 from rapidly exchanging body stores. Consequently, at the start of the test, a greater-than-normal proportion of the metabolic CO 2 production will initially be diverted into the depleted body stores to recharge them back to normal levels, with less therefore reaching the lungs and less being cleared at the mouth. Over this period, the _ VCO 2 e _ VO 2 slope and RER are thus abnormally low. When the CO 2 to reference values is: >80% not abnormal or within the 95% confidence interval; 71e80% mildly reduced; 51e70% moderately reduced; and < 50% severely reduced. 91 It should be appreciated however that the majority of clinical cohorts in surgical patients have reported _ VO 2peak as an absolute value indexed to body weight rather than as a percentage of predicted value. 11 As a consequence the published risk thresholds for surgical patients preoperatively are absolute values of AT and _ VO 2peak indexed to body weight. Indexing to body weight may have implications for patients at extremes of bodyweight, potentially over-estimating risk in the morbidly obese patient and under-estimating risk in cachectic patients. Despite this consideration, in morbidly obese bariatric patients, AT indexed to absolute body weight was more predictive of outcome than AT indexed to body surface area or to ideal body weight. 24 Caution should be used when interpreting exercise capacity values indexed to body weight in patients with a low BMI. Indexing to ideal bodyweight may be considered.
Ventilatory equivalents for carbon dioxide _ VE= _ VCO 2
The ventilatory equivalent for carbon dioxide ( _ VE= _ VCO 2 ) is the ratio of minute ventilation ð _ VEÞ to CO 2 output ( _ VCO 2 ) and as such is an index of 'ventilatory efficiency.' Greater-thannormal values indicate that either the physiological dead space fraction of the breath (dead space/tidal volume, reflective of pulmonary gas exchange efficiency) is abnormally increased, Pa CO2 is decreased (e.g. acute hyperventilation), or both. 3, 15 Thus, _ VE= _ VCO 2 gives insight into the efficiency of ventilationeperfusion matching in the lung and the efficiency of gas exchange. The slope of the linear _ VE= _ VCO 2 relationship Δ _ VE=Δ _ VCO 2 , the ventilatory equivalent for CO 2 at the AT ( _ VE= _ VCO 2AT ) or, if the AT cannot reliably be estimated, the minimum value of _ VE= _ VCO 2 ( _ VE= _ VCO 2min ) are numerically similar. 15 This allows the investigator to choose which of the three is most amenable to measurement in the test. The values are elevated in heart failure, respiratory disease, and pulmonary hypertension. 3, 15, 94 Furthermore, elevated _ VE= _ VCO 2 is predictive of mortality and disease progression in cardiac failure, 95e97 and mortality and other outcomes in chronic obstructive pulmonary disease and other respiratory diseases. 14, 98, 99 In the perioperative setting, _ VE= _ VCO 2 at the anaerobic threshold is associated with morbidity and mortality in hepatobiliary surgery, 100, 101 abdominal aortic aneurysm surgery, 26, 102 urological surgery, 103 and mixed surgical cohorts. 17 Recent thoracic surgical cohorts suggest the _ VE= _ VCO 2 slope may be more predictive of postoperative mortality and pulmonary complications than _ VO 2peak , although this requires further clarification.
104e106 However, an association between _ VE= _ VCO 2 and surgical outcome has not been identified in all cohorts, with some studies reporting no predictive association. 16 Further studies are required to clarify the additional risk conferred by abnormal ventilatory efficiency in addition to impaired exercise capacity.
The perioperative CPET report (Grade C, good practice recommendations, unless otherwise stated)
It is recommended that the perioperative CPET report includes: (1) reason for referral, relevant past medical history, and drug history; (2) CPET data, presented in tabular form and graphically; (3) a description of the patient's exercise capacity and its normality or otherwise; (4) a summary of the cause(s) of exercise limitation if exercise capacity is abnormal; (5) a statement about the risk implications of the exercise limitation and other identified abnormalities (Grade D); and (6) suggestions for possible referrals and interventions preoperatively (Grade D). An example of a tabular report with a suggested minimum data set is presented in Fig. 5 . In addition it is conventional practice to present CPET data graphically in the report in a multipanel format, typically with eight or nine panels (Fig. 6) . 3, 4, 15 It should be emphasized that the difference between the original Wasserman and the European Respiratory Society formats lies more in data presentation rather than in overall content. An advantage of the European Respiratory Society format in the perioperative setting is that the panels required for AT estimation are conveniently placed in a single column to aid discrimination decisions across the three criterion indices (a practice that has been adopted in the updated Wasserman 2011 format 15 ). For this reason, the European Respiratory Society format tends to be preferred for perioperative CPET, with the option for including a ninth panel as a non-assigned panel that can usefully be used for tailoring test results to allow, for example, tracking of temporal responses of interest (Fig. 6) . Interpretation with regard to normality is done against published normal-value databases and algorithms. 3, 15, 91 Risk thresholds in perioperative CPET Specific recommendations about risk thresholds and recommendations for perioperative care are outside the remit of these guidelines. As surgical and perioperative practice evolves, risk thresholds are likely to change. Furthermore, it is likely that the variables used to predict risk are likely to evolve and expand. Practitioners should evaluate local data and published cohorts on a regular basis to guide these recommendations. Further research is required to accurately enumerate the absolute risk of morbidity and mortality associated with different levels of functional capacity. National data collection is planned by POETTS, to provide access to contemporaneous risk threshold data. A summary of current case cohorts is presented in Supplementary Appendix S2.
Summary
The dynamic metabolic challenge imposed by perioperative CPET provides an objective means of evaluating exercise capacity. It can be used to evaluate chronic comorbidities and may enable identification of new pathology that requires treatment, optimization, or both preoperatively. The data derived from CPET may be used to inform collaborative (shared) decision-making and the process of consent, to triage patients to high dependency care, and to direct individualized exercise training programmes pre-and postoperatively. If CPET data are to help determine surgical patients perioperative care, it is essential that CPET procedures are reproducible and of high quality. This requires laboratory equipment to be maintained, calibrated, and validated regularly. Standardized exercise protocols with standardized graphical display of key variables to describe exercise capacity, and to investigate possible causes of exercise intolerance should be employed. These guidelines provide direction for clinicians performing and interpreting CPET on perioperative patients.
